Methylene Blue

methylthioninium chloride

Methylene blue is the world's oldest synthetic drug — a 19th-century textile dye that became a malaria treatment, then a methemoglobinemia antidote, and now a fringe cognitive supplement. The biology is real. The serotonin syndrome risk is also real.

Mitochondrial electron carrier / monoamine oxidase inhibitorEvidence C
⚠ Not medical advice.Not medical advice. This page is educational. Discuss with your physician before starting, changing, or stopping any medication.

Why it matters

Methylene blue does something genuinely unusual at the cellular level: it acts as an artificial electron shuttle in the mitochondrial respiratory chain, donating electrons directly to cytochrome c and bypassing damaged complexes. In aged or hypoxic tissue this can rescue ATP production. The preclinical and small-trial human data is intriguing for traumatic brain injury, cognitive aging, and possibly early Alzheimer's. But methylene blue is also a potent reversible MAOI — and this is the part that gets people hospitalized. The FDA issued a Drug Safety Communication in 2011 after multiple cases of serotonin syndrome in surgical patients given IV methylene blue while on SSRIs. The same risk applies to oral use. Anyone on an SSRI, SNRI, MAOI, tramadol, dextromethorphan, MDMA, St John's Wort, 5-HTP, or a triptan cannot safely take methylene blue without a multi-week wash-out. Beyond that, the "biohacker dose" market is a regulatory blind spot: lab-grade is not pharmaceutical-grade, and industrial dye contains heavy metals. If you want to experiment, USP-grade only, microdose start, full medication review.

Uses

Label uses (approved)
  • Methemoglobinemia (FDA-approved, IV)
  • Cyanide poisoning (historical/emergency)
  • Ifosfamide-induced encephalopathy
Off-label (educational only)
  • Cognitive enhancement / focusweak
  • Adjunct in early Alzheimer's disease (research)weak
  • Traumatic brain injury recovery (preclinical)weak
  • Antimicrobial / antimalarial (historical)moderate

Dosing

Label dose
Methemoglobinemia: 1-2 mg/kg IV over 5 minutes.
Off-label / biohacker dose
Oral cognitive use (research-grade, NOT recommended without supervision): 0.5-2 mg/kg pharmaceutical-grade only. Most cognitive protocols cite 0.5-4 mg total daily — small doses, never the IV concentrations.
Titration: Pharmaceutical-grade (USP) only. Industrial / aquarium / textile methylene blue contains heavy metals and is unsafe. Start microdose (0.5-1 mg) to assess tolerance. Stains saliva, urine, sweat, and contact lenses blue-green — this is harmless but cosmetically alarming.
When to take: Morning, on empty stomach. Pro-oxidant effects at higher doses make evening dosing inadvisable.

Side effects & warnings

Common
  • Blue/green discoloration of urine and saliva
  • Nausea
  • Headache
  • Mild dizziness
  • Sweating
Uncommon but serious
  • Abdominal pain
  • Diarrhea
  • Hypertension
  • Skin sensitivity to light
Serious warnings
CRITICAL: Methylene blue is a potent MAOI. Combining with serotonergic drugs (SSRIs, SNRIs, MAOIs, tramadol, MDMA, dextromethorphan, St John's Wort, 5-HTP, triptans) can trigger life-threatening serotonin syndrome. The FDA issued a 2011 Drug Safety Communication on this interaction. Wash-out periods of 2-5 weeks are required when switching from SSRIs. Also contraindicated in G6PD deficiency (causes hemolytic anemia).

Biomarkers affected

Monitoring

Screen for G6PD deficiency before use. Review all medications for serotonergic agents. Monitor blood pressure during initiation.

The honest risk picture

## Serious Risks **Serotonin syndrome** is the headline risk. Methylene blue is a potent MAO-A inhibitor. Combining it with any serotonergic agent — SSRIs, SNRIs, MAOIs, tramadol, MDMA, dextromethorphan, St John's Wort, 5-HTP, triptans, fentanyl, pethidine — can produce life-threatening serotonin syndrome (hyperthermia, agitation, clonus, autonomic instability, death). The FDA issued a 2011 Drug Safety Communication. A 2-week wash-out is the minimum after stopping an SSRI (5 weeks for fluoxetine). **G6PD deficiency:** Methylene blue causes acute hemolytic anemia in G6PD-deficient patients. Screen before use, especially in Mediterranean, African, and Southeast Asian backgrounds. **Hypertensive crisis:** As an MAOI, methylene blue can interact with tyramine-rich foods (aged cheese, cured meats, wine) at high doses. ## Practical Cautions - **Pharmaceutical-grade only.** Aquarium, textile, and industrial methylene blue contains heavy metals (arsenic, cadmium) and is unsafe. - **Purity of "lab-grade" supplements varies wildly.** Independent COAs are essential. - **Pro-oxidant at higher doses.** The therapeutic window is narrow — <2 mg/kg is antioxidant, higher doses generate ROS. - **Stains everything.** Saliva, urine, tongue, skin, and contact lenses turn blue-green. This is cosmetic, not dangerous. - **Photosensitivity:** Avoid intense UV exposure during use. - **Not for pregnancy:** Crosses placenta; teratogenic in animal studies.

Practical context

Cost (US, retail)
$40/mo
Legality
Pharmaceutical-grade is prescription-only in the US (FDA-approved injection for methemoglobinemia). "Lab-grade" oral methylene blue sold as a supplement is unregulated — purity varies dramatically. Industrial-grade is unsafe for human consumption.
Interactions
true

FAQ

Can I take methylene blue with my SSRI?+
No. This combination can cause serotonin syndrome, which is potentially fatal. The FDA issued a formal warning in 2011. If you are on any SSRI, SNRI, MAOI, tramadol, triptan, or St John's Wort, do not take methylene blue.
Why does my urine turn blue?+
Methylene blue is excreted partially unchanged in urine and saliva, producing a blue-green color. This is harmless and resolves within 24-48 hours of discontinuation.
Is aquarium methylene blue safe to take?+
Absolutely not. Industrial, aquarium, and textile-grade methylene blue contains heavy metals including arsenic, cadmium, and mercury. Only USP pharmaceutical-grade is safe for human use.
Does methylene blue actually improve cognition?+
Evidence is preliminary. Telch 2014 showed memory consolidation improvement in a small functional MRI study. Larger trials have not confirmed durable cognitive enhancement in healthy adults.
References (5)+
  1. .
  2. .
  3. .
  4. .
  5. .
The prime report

Weekly performance intelligence.

New studies, protocols, and optimization frameworks delivered every Monday. No fluff, no motivation quotes — only what moves the needle.

No spam. Unsubscribe anytime.